Evidence map›Paper›PMID 35103824›Full record

ArticleIntensive care medicine2022

Mental health symptoms in family members of COVID-19 ICU survivors 3 and 12 months after ICU admission: a multicentre prospective cohort study.

Hidde Heesakkers, Johannes G van der Hoeven, Stijn Corsten, Inge Janssen, Esther Ewalds, Dominique Burgers-Bonthuis, Thijs C D Rettig, Crétien Jacobs, Susanne van Santen, Arjen J C Slooter and 3 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Intensive care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 2 countries.

Hidde HeesakkersRadboud Institute for Health Sciences, Department Intensive Care Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. Hidde.heesakkers@radboudumc.nl.ORCID 0000-0002-6330-7208
Johannes G van der HoevenRadboud Institute for Health Sciences, Department Intensive Care Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Stijn CorstenDepartment of Intensive Care Medicine, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Inge JanssenDepartment of Intensive Care Medicine, Maasziekenhuis Pantein, Beugen, The Netherlands.
Esther EwaldsDepartment of Intensive Care Medicine, Bernhoven Hospital, Uden, The Netherlands.
Dominique Burgers-BonthuisDepartment of Intensive Care Medicine, Rijnstate Hospital, Arnhem, The Netherlands.
Thijs C D RettigDepartment of Anesthesiology, Intensive Care and Pain Medicine, Amphia Hospital, Breda, The Netherlands.
Crétien JacobsDepartment of Intensive Care Medicine, Elkerliek Hospital, Helmond, The Netherlands.
Susanne van SantenDepartment of Intensive Care Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
Arjen J C SlooterDepartment of Intensive Care Medicine and UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Margaretha C E van der WoudeDepartment of Intensive Care, Heerlen Medical Center, Heerlen, The Netherlands.
Marieke Zegers *Radboud Institute for Health Sciences, Department Intensive Care Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Mark van den Boogaard *Radboud Institute for Health Sciences, Department Intensive Care Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. Mark.vandenboogaard@radboudumc.nl.
Radboud University Nijmegen · NLAmphia Ziekenhuis · NLCanisius-Wilhelmina Ziekenhuis · NLDe Wever-Ziekenhuis · NLElkerliek Ziekenhuis · NLMaaslandziekenhuis · NLMaastricht University · NLRijnstate Hospital · NLVrije Universiteit Brussel · BEZiekenhuis Bernhoven · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLong-term mental outcomes in family members of coronavirus disease 2019 (COVID-19) intensive care unit (ICU) survivors are unknown. Therefore, we assessed the prevalence of mental health symptoms, including associated risk factors, and quality of life (QoL) in family members of COVID-19 ICU survivors 3 and 12 months post-ICU.

methodsA prospective multicentre cohort study in ICUs of ten Dutch hospitals, including adult family members of COVID-19 ICU survivors admitted between March 1, and July 1, 2020. Symptom prevalence rates of anxiety, depression (Hospital Anxiety and Depression Scale) and Post-Traumatic Stress Disorder (Impact of Event Scale-6), and QoL (Short Form-12) before ICU admission (baseline), and after 3 and 12 months were measured. Additionally, associations between family and patient characteristics and mental health symptoms were calculated.

resultsA total of 166 out of 197 (84.3%) included family members completed the 12-month follow-up of whom 46.1% and 38.3% had mental health symptoms 3 and 12 months post-ICU, respectively; both higher compared to baseline (22.4%) (p < 0.001). The mental component summary score of the SF-12 was lower at 12-month follow-up compared with baseline [mean difference mental component score: - 5.5 (95% confidence interval (CI) - 7.4 to - 3.6)]. Furthermore, 27.9% experienced work-related problems. Symptoms of anxiety (odds ratio (OR) 9.23; 95% CI 2.296-37.24; p = 0.002) and depression (OR 5.96; 95% CI 1.29-27.42; p = 0.02) prior to ICU admission were identified as risk factors for mental health symptoms after 12 months.

conclusionA considerable proportion of family members of COVID-19 survivors reported mental health symptoms 3 and 12 months after ICU admission, disrupting QoL and creating work-related problems.

Indexed as

COVID-19Stress Disorders, Post-TraumaticAdultAnxietyCohort StudiesDepressionFamilyHumansIntensive Care UnitsMental HealthProspective StudiesQuality of LifeSARS-CoV-2SurvivorsCOVID-19Critical careFamily membersMental healthQuality of life

Identifiers

PMID35103824
PMCPMC8804080
OpenAlexW4210747991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.